It’s no secret that the U.S. elderly population is only growing, and with that will be an increased prevalence of chronic diseases — and dementia is no exception.
The Milken Institute Center for the Future of Aging, an independent economic think tank, found that the prevalence of Alzheimer’s Disease and related dementias (or ADRD) treatment has soared, with costs increasing by 31% since 2012, totaling to $60.3 billion last year. However, women and people of color may find themselves at a disproportionate risk for dementia and the financial burden that comes with it.
